Effects of DASH Diet on Corticosteroids Medication Use
This study has been completed.
Sponsor:
Isfahan University of Medical Sciences
Information provided by (Responsible Party):
Leila Azadbakht, Isfahan University of Medical Sciences
ClinicalTrials.gov Identifier:
NCT01762267
First received: December 1, 2012
Last updated: January 4, 2013
Last verified: January 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To determine the effects of the Dietary Approaches to Stop Hypertension (DASH) diet on the metabolic side effects of corticosteroids medications use.
| Condition | Intervention | Phase |
|---|---|---|
|
Nutritional and Metabolic Disease |
Other: nutrition intervention |
Phase 3 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Health Services Research |
| Official Title: | Phase 3 Study of Beneficiary Effects of Dietary Approaches to Stop Hypertension (DASH) on the Metabolic Aeffects of Corticosteroids Medications Use |
Resource links provided by NLM:
Further study details as provided by Isfahan University of Medical Sciences:
Primary Outcome Measures:
- the amount of weight reduction and change of blood pressure [ Time Frame: up to 10 weeks ] [ Designated as safety issue: Yes ]weight (kg) body mass index (kg/m2) blood pressure (mmHg)
Secondary Outcome Measures:
- lipid profile, fasting blood glucose [ Time Frame: 10 weeks ] [ Designated as safety issue: Yes ]measurement of LDL-C (mg/dl), HDL-C (mg/dl), triglyceride (mg/dl), total cholesterol (mg/dl), fasting blood glucose(mg/dl), by the analysis of blood samples and blood pressure(mmHg) and weight (kg), waist circumference (cm), body mass index (kg/m2).
Other Outcome Measures:
- lipid profile (mg/dl), fasting blood glucose (mg/dl), blood pressure (mmHg), weight reduction (kg) [ Time Frame: july ] [ Designated as safety issue: Yes ]
| Enrollment: | 62 |
| Study Start Date: | January 2011 |
| Study Completion Date: | July 2012 |
| Primary Completion Date: | June 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Active Comparator: diet intervention, DASH diet
intervention: nutrition intervention: DASH diet
|
Other: nutrition intervention
DASH diet control diet
|
|
No Intervention: not intervention, control diet
control weight loss diet
|
Detailed Description:
Objective: To determine the effects of the Dietary Approaches to Stop Hypertension (DASH) diet on the metabolic side effects of corticosteroids medications use.
Design: A randomized clinical trial was undertaken in 60 patients on corticosteroid therapy for 10 weeks. Patients were randomly assigned to a DASH or control diet. Fasting blood sample were measured to determine blood glucose and lipid profile. Blood pressure and anthropometric measurements were measured based on the standard guidelines.
Eligibility| Ages Eligible for Study: | 27 Years to 35 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- patients who were on corticosteroid therapy
Exclusion Criteria:
- refuse to follow the visits
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01762267
Locations
| Iran, Islamic Republic of | |
| 1. Department of Community Nutrition, School of Nutrition & Food Science, Isfahan University of Medical Science | |
| Isfahan, Iran, Islamic Republic of | |
Sponsors and Collaborators
Isfahan University of Medical Sciences
Investigators
| Study Director: | Leila azadbakht, PhD | 1. Department of Community Nutrition, School of Nutrition & Food Science, Isfahan University of Medical Science, Isfahan, Iran |
More Information
No publications provided
| Responsible Party: | Leila Azadbakht, Isfahan University of Medical Sciences |
| ClinicalTrials.gov Identifier: | NCT01762267 History of Changes |
| Other Study ID Numbers: | DASH in corton therapy |
| Study First Received: | December 1, 2012 |
| Last Updated: | January 4, 2013 |
| Health Authority: | Iran: Ethics Committee |
Additional relevant MeSH terms:
|
Metabolic Diseases |
ClinicalTrials.gov processed this record on May 22, 2013